Quarterly pharmacy formulary change notice

Similar documents
Current as of November 1, 2017

Care Wisconsin 2018 Formulary Addendum

ATRIO Health Plans 2018 PPO Plans Formulary Change Notice

ATRIO Health Plans 2018 SNP Plans Formulary Change Notice

Acyclovir Ointment. Aetna Better Health New Jersey. Products Affected. acyclovir ointment 5 % external Details. Criteria

Acyclovir Ointment. Aetna Better Health Virginia Medallion/FAMIS 3.0. Products Affected. acyclovir ointment 5 % external Details.

Acyclovir Ointment. Aetna Better Health Kentucky. Products Affected. acyclovir ointment 5 % external Details. Criteria

Acyclovir Ointment. Aetna Better Health Louisiana. Products Affected. acyclovir ointment 5 % external Details. Criteria

Provider Partners Pennsylvania Advantage Plan Offered by Provider Partners Health Plan April 2019 Formulary Addendum

92:00. Miscellaneous Therapeutic Agents. 92:00 Miscellaneous Therapeutic Agents

AgeWell 1-Tier 2017 Formulary Addendum

Care Wisconsin 2017 Formulary Addendum

Step Therapy Criteria Last Updated 6/1/2018

Upcoming Changes to Retiree RxCare s 5 Tier Formulary

Postmenopausal Hormone Therapy

Androgens and Anabolic Steroids Prior Authorization with Quantity Limit - Through Preferred Topical Androgen Agent

FINASTERIDE PER ALOPECIA ANDROGENETICA FEMMINILE

Natural Hair Transplant Medical Center, Inc Dove Street, Suite #250, Newport Beach, CA Phone

List of Covered Drugs (Formulary)

Memorial Hermann Advantage HMO & PPO April 2018 Formulary Addendum

2011 PROHIBITED DRUG CLASSES AND METHODS. Dr Nicolas Theron Loch Logan Waterfront Sport and Travel Medicine Centre Tel :

Antibiotic Treatments. Arthritis & Pain. Asthma. Cholesterol

Clinical Policy: Testosterone Reference Number: AZ.CP.PHAR.02 Effective Date: Last Review Date: Line of Business: Arizona Medicaid

Gastrointestinal Drugs

2016 STEP THERAPY CRITERIA

All About T Testosterone for FTMs. Presented by John Otto, MLIS

Allergies and Cold & Flu

DUPROST Capsules (Dutasteride)

CHAPTER 10 Reconstitution of Powdered Drugs

Health Products Regulatory Authority

2019 Formulary (List of Covered Drugs)

WELLCARE HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 10/2014)

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

3. This solution retains potency for 2 8 hours at room temperature after reconstitution.

Diana Heiman, MD Associate Professor, Family Medicine Residency Director East Tennessee State University

TEV-TROPIN [somatropin (rdna origin) for injection] 5 mg & 10 mg

Subject: Hereditary Angioedema Drug Therapy

BANNED & RESTRICTED SUBTANCES IN SPORTS

Elements for a Public Summary. Overview of disease epidemiology

PHYSICIANS CIRCULAR FINASTERIDE PROSCAR. Tablet 5-Alpha Reductase Inhibitor

FULL PRESCRIBING INFORMATION

See Important Reminder at the end of this policy for important regulatory and legal information.

Appendix *Participating Pfizer Products

Elements for a public summary

Formulary. IEHP DualChoice Cal MediConnect Plan. (Medicare-Medicaid Plan) IEHP (4347) TTY

FINASTERIDE (PROPECIA, PROSCAR) SIDE EFFECT & CONSENT FORM

Membership Clinic 2015

Dextromethorphan Overutilization

ADOPTED REGULATION OF THE STATE BOARD OF PHARMACY. LCB File No. R Effective November 14, 1997

Formulary. IEHP DualChoice Cal MediConnect Plan. June. (Medicare-Medicaid Plan) IEHP (4347) TTY

Advance Notification of Amendments to the March 2015 Drug Tariff

Mens Health Post Puberty. Nayan Patel PharmD

See 17 for PATIENT COUNSELING INFORMATION and FDAapproved. Revised: 11/2017

2018 Formulary (List of Covered Drugs)

See Important Reminder at the end of this policy for important regulatory and legal information.

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

2017 Drug Formulary. List of Covered Drugs for 2017 PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Formulary. IEHP DualChoice Cal MediConnect Plan. (Medicare-Medicaid Plan) IEHP (4347) TTY

Dutasteride Avodart Softgel Capsule

It is estimated that 24% to 90% of US men older than the age of

BEST FINASTERIDE IN INDIA

SUMMARY OF PRODUCT CHARACTERISTICS

Prostate enlargement, also known as benign prostatic hyperplasia

Haldol lactate vs haldol decanoate

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Associate Professor Geoff Braatvedt

Product Monograph. Sandoz Dutasteride

2018 Comprehensive Formulary (List of Covered Drugs) Medicare Advantage Plans

FEMALE HORMONE THERAPY OPTIONS

AVODART (dutasteride) Soft Gelatin Capsules

AVODART (dutasteride) Soft Gelatin Capsules

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

1001 West Broadway, Vancouver, BC V6H 4B1. Topical Finasteride

3. PHARMACEUTICAL FORM Capsules: dull yellow in colour, opaque, oblong soft gelatin capsules with GX CE2 printed on one side in red ink.

2017 Comprehensive Formulary (List of Covered Drugs) Medicare Advantage Plans

Map and Application of States That Require a Prescription for Dispensing Ephedrine

PACKAGE LEAFLET: INFORMATION FOR THE USER. FINASTERIDE 1 MG FILM-COATED TABLETS (finasteride)

Mixing Methacholine Dilutions for Bronchoprovocation Challenge Testing

COMPREHENSIVE FORMULARY

IS ULTRAM A CONTROLLED SUBSTANCE IN NORTH CAROLINA

Provider Partners Health Plan of Ohio (HMO SNP) 2019 Formulary (List of Covered Drugs)

FINCAR Tablets (Finasteride)

Drugs in Sport. Fifth Edition. Edited by David R. Mottram. Routledge. Taylor & Francis Group LONDON AND NEW YORK

Urogenitalsystem og kjønnshormoner Genito urinary system and sex hormones

3 Tier Formulary (List of Covered Drugs)

2018 Comprehensive Formulary (List of Covered Drugs) Prescription Drug Plans

2018 Comprehensive Formulary (List of Covered Drugs) Medicare Advantage Plans

6.25 mg 1 tab, PO, BIDMEALS, Take with Meals, Duration: 30 day (DEF)*

Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor

2018 Comprehensive Formulary (List of Covered Drugs) Medicare Advantage Plans

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

DUTASTERIDE capsules, for oral use Initial U.S. Approval: 2001

SUMMARY OF PRODUCT CHARACTERISTICS

This is an English translation of the original Chinese instruction leaflet generated by Google Translate. No amendments were made.

MALE HORMONE THERAPY OPTIONS

Public Assessment Report. Scientific discussion. Dutasteride Regiomedica 0.5 mg capsules, soft (dutasteride) NL/H/2861/001/DC.

Provider Partners Illinois Advantage Plan (HMO SNP) 2019 Formulary (List of Covered Drugs)

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Simultaneous Determination of a Panel of 22 Steroids in Urine and Serum by SPE and LC-MS/MS

Transcription:

Provider Bulletin December 2017 Quarterly pharmacy formulary notice The formulary s listed in the table below apply to all Anthem HealthKeepers Plus members. These s were reviewed and approved at the third quarter Pharmacy and Therapeutics Committee meeting. Effective February 1, 2018, formulary s, non-formulary s and prior authorization requirements will apply. Effective for all Anthem HealthKeepers Plus members on February 1, 2018 ANTIPSYCHOTICS PIMOZIDE 1 MG PIMOZIDE 2 MG ESTROGEN COMBINATIONS ESTROGEN COMBINATIONS HEPATITIS C IRON REPLACEMENT CAFFEINE SODIUM POLYSTYRENE SULFONATE SEVELAMER CARBONATE OPHTHALMOLOGICS OPTHALMIC ANTI-INFECTIVES EEMT DS 1.25-2.5 MG EEMT HS 0.625-1.25 MG COVARYX COVARYX H.S. MIMVEY LO 0.5-0.1 MG LOPREEZA 1 MG-0.5 MG EPCLUSA 400 MG-100 MG MAVYRET 100-40 MG HEMORRHOIDAL SUPPOSITORIES SOD FER GLUC CPLX 62.5 MG/5 ML NON- NON- WITH PA WITH PA AS OF 11/1/17 PREMPHASE PREMPRO MIMVEY LO LOPREEZA ZEPATIER MAVYRET WITH CAFFEINE CIT 60 MG/3 ML VIAL SPS 50 GM/200 ML ENEMA KIONEX 15 GM/60 ML SUSPENSION NON- AZO TEST STRIP SEVELAMER CARBONATE 800 MG TAB NON- PROPARACAINE 0.5% EYE DROPS NON- ARTIFICIALS TEARS DROPS GATIFLOXACIN 0.5% EYE DROPS MOXIFLOXACIN 0.5% EYE DROPS (GENERIC VIGAMOX) SPS 15 GM/60 ML SUSPENSION SPS 30 GM/120 ML ENEMA VELPHORO 500 MG CHEWABLE TAB The information in this bulletin may be an update or to your provider manual. Find the most current manual at: https://mediproviders.anthem.com/va HealthKeepers, Inc. is an independent licensee of the Blue Cross and Blue Shield Association. ANTHEM is a registered trademark of Anthem Insurance Companies, Inc. AVAPEC-1579-17 December 2017

Quarterly pharmacy formulary notice Page 2 of 5 OXYTOCICS URINARY ANESTHETICS UROLOGICALS VAGINAL CLEANSER /ANTIINFECTIVES VAGINAL ANTIFUNGALS VASOCONSTRICTOR DECONGESTANTS METHYLERGONOVINE 0.2 MG/ML AMP METHYLERGONOVINE 0.2 MG/ML VL AZO-TABS 95 MG URETRON D-S URIN D.S. NON- FEM PH VAGINAL JELLY NON- MICONAZOLE 1 COMBINATION PACK TIOCONAZOLE 1 6.5% OINTMENT EYE ALLERGY RELIEF DROP VISINE-A EYE DROPS EYE DROPS ADVANCED RELIEF NAPHAZOLINE 0.1% EYE DROPS EDITS NO CHANGES IN /NON- STATUS REVISION OR ADDITION TO UM EDIT ONLY BPH 5-ALPHA- REDUCTASE INHIB-ALPHA1- ADRENOCEP ANTAG ADHD ANTI-INFECTIVES ANTIMETABOLITES ANTICOAGULANTS ANTINEOPLASTICS AVODART DUTASTERIDE DUTASTERIDE-TAMSULOSIN FINASTERIDE JALYN PROSCAR MYDAYIS ER 12.5 MG CAPSULE MYDAYIS ER 25 MG CAPSULE MYDAYIS ER 37.5 MG CAPSULE MYDAYIS ER 50 MG CAPSULE DAXBIA 333 MG CAPSULE XATMEP 2.5 MG/ML ORAL SOLUTION BEVYXXA 40 MG CAPSULE BEVYXXA 80 MG CAPSULE KISQALI FEMARA 200 MG KISQALI FEMARA 400 MG KISQALI FEMARA 600 MG RUBRACA 250 MG ZYTIGA 500 MG AL REMOVED 168 PER 30 ADD PA 31 PER 30 LIMIT OF 42 SUPPLY IN 60 1 CARTON PER 30

Quarterly pharmacy formulary notice Page 3 of 5 ANTIPARKINSONISM ANTIPSORIATIC ANTIPSYCHOTICS ANTISPASMODICS ANTIVIRALS CODEINE CONTAINING HEPATITIS C GROWTH HORMONES GASTROINTESTINAL HYPERPARATHYROIDISM HYPNOTIC INTRANASAL STEROIDS LIPID/CHOLESTEROL LOWERING TO TREAT MULTIPLE SCLEROSIS XADAGO 50 MG XADAGO 100 MG ZELAPAR 1.25 MG ODT TREMFYA 100 MG/ML FAZACLO 200 MG ODT CLOZAPINE ODT 200 MG CLOZAPINE 200 MG GELNIQUE 10% GEL PUMP FAMCICLOVIR 125 MG FAMCICLOVIR 250 MG VALTREX 500 MG CAPLET VALACYCLOVIR HCL 500 MG ALL RX AND OTC PRODUCTS RIBAVIRIN 200 MG CAPSULE RIBAVIRIN 200 MG SAIZEN 8.8 MG CLICK.EASY CARTG SAIZEN 8.8 MG SAIZENPREP CART RENFLEXIS 100 MG VIAL RAYALDEE 30MCG SENSIPAR 30MG & 60MG SENSIPAR 90MG BUTISOL SODIUM 30 MG/5 ML ELX BUTISOL SODIUM 30 MG FLUTICASONE 50 MCG SPRAY NASACORT ALLERGY 24 HR FLONASE SENSIMIST 27.5 MCG SPR VASCEPA 0.5 MG ZINBRYTA 150 MG/ML 1 PER 56 QL REVISION 1 PUMP PER 30 60 PER 30 ADD AL <12 YEARS OLD PA REMOVED 1 CARTRIDGE PER DAY 2 PER 28 NEW: 14 DAY TREATMENT PERIOD 1 PER 30 8 PER DAY 1 PER 28

Quarterly pharmacy formulary notice Page 4 of 5 NARCOTICS NARCOTIC ANTAGONISTS OSTEOPOROSIS THERAPY PROTON-PUMP INHIBITORS PULMONARY RHEUMATOLOGICAL SODIUM HENYLBUTYRATE CHOLESTEROL LOWERING VACCINES LAZANDA 300 MCG NASAL SPRAY EVZIO 0.4 MG AUTO-INJECTOR EVZIO 2 MG AUTO-INJECTOR NARCAN 2MG NASAL SPRAY TYMLOS 80 MCG DOSE PEN INJECTR ZEGERID OTC 20-1;100 MG CAP HAEGARDA 3;000 UNIT VIAL HAEGARDA 2;000 UNIT VIAL KEVZARA 150 MG/1.14 ML KEVZARA 200 MG/1.14 ML ORENCIA 50 MG/0.4 ML ORENCIA 87.5 MG/0.7 ML BUPHENYL 500MG BUPHENYL 250GM POWDER NIKITA 1MG, 2MG, 4MG ZYPITAMAG 1MG, 2MG, 4MG FENOFIBRATE 43 MG CAPSULE FENOFIBRATE 130 MG CAPSULE FLU VACCINATIONS 1 BOTTLE PER DAY 6 INJ PER 90 3 CARTONS PER 90 1 PEN PER 30 QL REVISION 16 VIALS PER 28 24 VIALS PER 28 2 PER 28 4 PER 28 40 PER DAY 250GM POWDER PER 12 0.5 ML PER FILL 2 FILLS PER 180

Quarterly pharmacy formulary notice Page 5 of 5 What action do I need to take? Please review these s and work with your Anthem HealthKeepers Plus members to transition them to formulary alternatives. If you determine formulary alternatives are not clinically appropriate for specific patients, you will need to obtain prior authorization to continue coverage beyond the applicable effective date. What if I need assistance? We recognize the unique aspects of patients cases. If a Anthem HealthKeepers Plus member cannot be converted to a formulary alternative, call our Pharmacy department at 1-800-901-0020 and follow the voice prompts for pharmacy prior authorization. You can find the preferred drug list (formulary) on our provider website at https://mediproviders.anthem.com/va. If you need assistance with any other item, contact your local Provider Relations representative or call Provider Services at 1-800-901-0020.